MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1371/journal.pone.0223380

Медицинская библиотека · PloS one · 2019

Dual antiplatelet therapy in patients with cirrhosis and acute myocardial infarction - A 13-year nationwide cohort study.

Wu Victor Chien-Chia, Chen Shao-Wei, Chou An-Hsun, Ting Pei-Chi, Chang Chih-Hsiang, Wu Michael, Hsieh Ming-Jer, Wang Chao-Yung, Chang Shang-Hung, Lin Ming-Shyan, Hung Kuo-Chun, Hsieh I-Chang, Chu Pao-Hsien, Wu Cheng-Shyong, Lin Yu-Sheng

СтатьяПеревод в очереди

Аннотация

BACKGROUND

Patients with cirrhosis and acute myocardial infarction (AMI) present dilemma whether dual antiplatelet therapy (DAPT) should be used.

METHODS

Electronic medical records between 2001-2013 were retrieved from Taiwan National Health Insurance Research Database. Patients were excluded for missing information, age <20 years old, history of AMI, liver transplant, autoimmune disease, coagulopathy, taking DAPT 3 months before index date, follow-up <3 months, anticoagulation user, without DAPT, and events of myocardial infarction (MI), ischemic stroke, major bleeding, and heart failure within 3-month of enrollment. Primary outcomes were 1-year all-cause mortality, recurrent MI, major bleeding, and gastrointestinal bleeding.

RESULTS

A total of 150,887 patients with AMI retrieved. After exclusion criteria and propensity score-matching, 914 cirrhotic and 3,656 non-cirrhotic patients with AMI on DAPT were studied. During 1-year follow-up, there was significantly increased mortality in cirrhotic patients compared to non-cirrhotic patients (HR = 1.49, 95% CI = 1.28-1.74). There was significantly decreased recurrent MI in cirrhotic patients compared to non-cirrhotic patients (subdistribution HR [SHR] = 0.71, 95% CI = 0.54-0.92). However, non-significantly increased major bleeding (SHR = 1.23, 95% CI = 0.87-1.73) and significantly increased gastrointestinal bleeding (SHR = 1.49, 95% CI = 1.31-1.70).

CONCLUSIONS

In cirrhotic patients with AMI, DAPT offers benefit with decreased recurrent MI at the expense of increased gastrointestinal bleeding.

Для цитирования: Wu Victor Chien-Chia, Chen Shao-Wei, Chou An-Hsun, Ting Pei-Chi, Chang Chih-Hsiang, Wu Michael, Hsieh Ming-Jer, Wang Chao-Yung, Chang Shang-Hung, Lin Ming-Shyan, Hung Kuo-Chun, Hsieh I-Chang, Chu Pao-Hsien, Wu Cheng-Shyong, Lin Yu-Sheng. Dual antiplatelet therapy in patients with cirrhosis and acute myocardial infarction - A 13-year nationwide cohort study.. PloS one. 2019. DOI: 10.1371/journal.pone.0223380.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.